ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,557Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 2588

$1.09M Total Retail Price of All Prescriptions

Rank: 73 out of 2588

486 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

34% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 950 406 S3 1 7
LISINOPRIL 719 500 2 3
LEVOTHYROXINE SODIUM 521 401 3 2
FUROSEMIDE 498 425 4 5
WARFARIN SODIUM 450 432 5 10
SIMVASTATIN 419 285 6 1
OMEPRAZOLE 396 244 7 6
AMLODIPINE BESYLATE 348 249 8 4
METOPROLOL TARTRATE 332 244 9 9
POTASSIUM CHLORIDE 288 201 10 15
CARVEDILOL 238 172 11 20
PANTOPRAZOLE SODIUM 238 165 11 28
HYDROCHLOROTHIAZIDE 236 133 13 13
SPIRONOLACTONE 215 106 14 58
CRESTOR 202 140 15 25
CLOPIDOGREL 198 144 16 30
DONEPEZIL HCL 182 169 17 22
LANTUS 172 136 18 47
KLOR-CON M20 172 147 18 52
NAMENDA 166 159 20 32
NEXIUM 164 121 21 41
CITALOPRAM HBR 164 141 21 27
ATENOLOL 162 121 23 14
PLAVIX 157 101 24 43
AZITHROMYCIN 157 87 24 45
DIGOXIN 146 104 26 38
FENTANYL 143 112 S2 27 78
ZOLPIDEM TARTRATE 137 93 28 24
METFORMIN HCL 132 95 29 8
GLIPIZIDE 130 99 30 44
HYDROCODONE BIT-IBUPROFEN 126 82 S3 31 311
GABAPENTIN 121 89 32 18
CYCLOBENZAPRINE HCL 120 68 R 33 87
HYDRALAZINE HCL 119 85 34 53
LOSARTAN POTASSIUM 115 91 35 17
TAMSULOSIN HCL 113 96 36 23
ALLOPURINOL 111 102 37 33
ATORVASTATIN CALCIUM 110 76 38 11
ISOSORBIDE MONONITRATE ER 109 50 39 49
TRAMADOL HCL 106 51 40 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 67 41 127
LOVASTATIN 95 85 42 34
PHENYTOIN SODIUM EXTENDED 95 33 42 109
SPIRIVA 88 40 44 56
LEVOFLOXACIN 87 47 45 77
KLOR-CON 10 87 70 45 75
NOVOLOG 87 67 45 103
INSULIN SYRINGE 87 41 45 81
AMIODARONE HCL 85 77 49 156
CLINDAMYCIN PHOSPHATE 82 50 50 335
GLYBURIDE 81 62 R 51 65
ESCITALOPRAM OXALATE 81 66 51 68
LOVAZA 80 49 53 119
PROAIR HFA 77 42 54 50
ADVAIR DISKUS 76 24 55 48
AMLODIPINE BESYLATE-BENAZEPRIL 74 66 56 76
CLONIDINE HCL 73 19 57 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 54 58 35
ALENDRONATE SODIUM 70 51 59 21
METOPROLOL SUCCINATE 68 46 60 12
ULORIC 66 47 61 310
SINGULAIR 65 50 62 94
LEVETIRACETAM 64 45 63 90
SERTRALINE HCL 63 28 64 26
CIPROFLOXACIN HCL 63 48 64 82
CLOTRIMAZOLE-BETAMETHASONE 62 40 66 155
BUMETANIDE 62 37 66 117
FLUTICASONE PROPIONATE 61 54 68 40
INDOMETHACIN 59 42 R 69 367
FENOFIBRATE 58 28 70 64
CYMBALTA 58 40 70 70
MIRTAZAPINE 55 42 72 63
DEXILANT 54 54 73 250
ACETAMINOPHEN-CODEINE 54 0 S3 73 80
SYMBICORT 53 38 75 129
AMOXICILLIN 53 20 75 130
DOXYCYCLINE HYCLATE 53 19 75 151
COMBIVENT 53 26 75 145
IBUPROFEN 51 25 79 62
OXYBUTYNIN CHLORIDE ER 51 45 79 85
TERAZOSIN HCL 50 46 81 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.